Patients with malignant pleural mesothelioma face barriers to treatment access
Chinese city with coronavirus outbreak stops buses, trains
12 September 2021School starts for 1 million NYC kids amid new vaccine rules
13 September 2021Patients with malignant pleural mesothelioma face barriers to treatment access
A study of 2,804 patients with stage I to stage III malignant pleural mesothelioma (MPM) found significant variability in access to care and a positive association between multimodality treatment, income levels, and survival outcomes. The research was presented today at the IASLC 2021 World Conference on Lung Cancer in OA13: Topics in Pleural Mesothelioma.
